{"id":"W2741543570","doi":"10.1158/1538-7445.am2017-ct054","title":"Abstract CT054: Phase II study of dianhydrogalactitol in patients with <i>MGMT</i>-unmethylated bevacizumab-naive recurrent glioblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Tolerability; Oncology; Regimen; Internal medicine; Phases of clinical research; Radiation therapy; Dacarbazine; Cancer research; Clinical trial; Chemotherapy; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006993302,0.001250428,0.001679206,0.0003904132,0.0003567657,0.0008540213,0.0009485789,0.0009122468,0.002926697],"category_scores_gemma":[0.0004937586,0.0004396212,0.0009946328,0.0004393173,0.0006764615,0.0006191903,0.0002652379,0.002619137,0.0009296511],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00114331,"about_ca_system_score_gemma":0.001538702,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002652361,"about_ca_topic_score_gemma":0.005436719,"domain_scores_codex":[0.9997688,0.00008799289,0.00001289099,0.00004635347,0.00002576829,0.00005825851],"domain_scores_gemma":[0.9996598,0.00002320912,0.00004929315,0.00002613494,0.00003191869,0.0002095711],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5929118,0.09877159,0.009119286,0.001162881,0.002434098,0.0005846646,0.0004367938,0.002996112,0.1303532,0.0005097367,0.009922171,0.1507977],"study_design_scores_gemma":[0.2916044,0.6769937,0.01538719,0.00005393696,0.0006711587,0.0003713787,0.00009842967,0.001888165,0.007895839,0.0002487039,0.004732464,0.00005467903],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933137,0.001725069,0.0004457649,0.0004728244,0.000152239,0.001344624,0.0009713098,0.0001467839,0.001427648],"genre_scores_gemma":[0.9895592,0.001415412,0.001192242,0.0008987257,0.0001110962,0.001336541,0.002821158,0.00003309894,0.002632524],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002926697,"threshold_uncertainty_score":0.009790838,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0585877034707482,"score_gpt":0.4280164182227051,"score_spread":0.3694287147519569,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}